Loading...

VTAK CATHETER PRECISION INC Product Launches 8-K Filing

CTHT

VTK

CATHETER PRECISION INC

(VTAK)

2025 8-K

Termination Notice

Financial Results Announcement

Stockholder Meeting Outcome

Product Approval Announcement

Stock Split Filed

Reverse Stock Split

Legal Opinion Filing

Dilution of Shares

Equity Offerings

Financial Statements

Equity Offerings

Asset Acquisitions

Asset Acquisition

Asset Acquisition

Financial Results

Investor Presentation

Executive Stock Options

Stockholder Meeting

CFO Appointment

Financial Results

Warrant Repricing

Warrant Exercise Waiver

Warrant Repricing

Public Offering

Financial Results

Reverse Stock Split

Stock Issuance Approval

Earnings Release & Reverse ...

Royalty Agreement with Aust...

Departure of Directors

Financial Results Announcement

Earnings Reports

Earnings Report

Private Placement

Earnings Report

Appointment of Directors an...

Resignation of Director

Financial Results Announcement

Financial Results Announcement

Earnings Reports

Appointment of Withum as In...

Financial Results Announcement

Financial Results

Annual Meeting of Shareholders

Resignation of CEO

Appointment of CFO

Private Placement with Armi...

Special Meeting and Stockho...

Proxy Statement for Special...

Merger Agreement

External Links:

Catheter Precision, Inc. reported the approval of its LockeT product in Great Britain on August 18, 2025, to enhance patient outcomes post-cardiac procedures.

AI Assistant

CATHETER PRECISION INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.